Vertex Pharmaceuticals Inc VRTX:NASDAQ

RT Quote | NASDAQ | USD
Last | 12/01/21 EST
205.00quote price arrow up+18.06 (+9.66%)
Volume
6,641,767
52 week range
176.36 - 242.99
Loading...
  • Open195.59
  • Day High205.85
  • Day Low194.10
  • Prev Close205.00
  • 52 Week High242.99
  • 52 Week High Date01/25/21
  • 52 Week Low176.36
  • 52 Week Low Date10/06/21

Key Stats

  • Market Cap53.183B
  • Shares Out259.43M
  • 10 Day Average Volume1.86M
  • Dividend-
  • Dividend Yield-
  • Beta0.62
  • YTD % Change-13.26

KEY STATS

  • Open195.59
  • Day High205.85
  • Day Low194.10
  • Prev Close205.00
  • 52 Week High242.99
  • 52 Week High Date01/25/21
  • 52 Week Low176.36
  • 52 Week Low Date10/06/21
  • Market Cap53.183B
  • Shares Out259.43M
  • 10 Day Average Volume1.86M
  • Dividend-
  • Dividend Yield-
  • Beta0.62
  • YTD % Change-13.26

RATIOS/PROFITABILITY

  • EPS (TTM)8.34
  • P/E (TTM)24.58
  • Fwd P/E (NTM)16.43
  • EBITDA (TTM)2.382B
  • ROE (TTM)23.83%
  • Revenue (TTM)6.684B
  • Gross Margin (TTM)87.89%
  • Net Margin (TTM)29.80%
  • Debt To Equity (MRQ)5.71%

EVENTS

  • Earnings Date01/31/2022
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Profile

MORE
Vertex Pharmaceuticals Incorporated is a biotechnology company. The Company is focused on developing and commercializing therapies for the treatment of cystic fibrosis (CF) and advancing its research and development programs in other indications. The Company's marketed medicines are TRIKAFTA/KAFTRIO, SYMDEKO/SYMKEVI, ORKAMBI and KALYDECO. It offers its products to treat people with CF who have specific mutations in their cystic fibrosis transmembrane conductance regulator...
Jeffrey Leiden M.D., Ph.D.
Chairman
Reshma Kewalramani M.D.
President
Stuart Arbuckle
Chief Operating Officer
Charles Wagner Jr.
Chief Financial Officer
Michael Parini J.D.
Executive Vice President
Address
50 Northern Ave
Boston, MA
02210-1862
United States

Top Peers

SYMBOLLASTCHG%CHG
TAK
Takeda Pharmaceutical Co Ltd
13.17-0.18-1.35%
SGEN
Seagen Inc
158.25-1.75-1.09%
CTLT
Catalent Inc
127.31-1.35-1.05%
HZNP
Horizon Therapeutics PLC
105.45+1.69+1.63%
RPRX
Royalty Pharma PLC
38.77-1.00-2.51%